Delivery Order SPE2DB24D1205-SPE2DB25FCZUR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count) valued at $2,057.66. The contract, which closed on August 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $2,136.69. The award, effective September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count) with a ceiling value of $6,451.66. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, under a firm fixed-price delivery order arrangement. No set-aside designation was utilized in this competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,401.40 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,530.00 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (90-count packaging) under a firm fixed-price contract type. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and no set-aside designation was utilized in this competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-unit package) valued at $2,510.96. This competitively awarded, firm fixed-price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100-count) with a ceiling value of $1,474.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (100-count units) under a firm fixed price contract valued at $3,094.80, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award was issued on August 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's ongoing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $1,141.26. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZURDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (90-count units) with a ceiling value of $1,171.95. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/22/25 |